Item | Treatmentb | P-value | |
---|---|---|---|
CON | AOS | ||
Duodenum, % | |||
 G0/G1 phase cells | 75.15 ± 1.41 | 70.65 ± 1.37 | 0.051 |
 S phase cells | 18.71 ± 1.25 | 22.05 ± 0.78 | 0.053 |
 G2 + M phase cells | 6.02 ± 1.05 | 6.54 ± 0.72 | 0.698 |
 Proliferating index | 24.77 ± 1.39 | 28.81 ± 1.28 | 0.064 |
Jejunum, % | |||
 G0/G1 phase cells | 75.93 ± 1.81 | 70.42 ± 0.78* | 0.023 |
 S phase cells | 16.66 ± 1.37 | 21.88 ± 0.87* | 0.012 |
 G2 + M phase cells | 5.98 ± 0.74 | 7.62 ± 0.55 | 0.112 |
 Proliferating index | 22.99 ± 1.51 | 29.53 ± 0.79** | 0.005 |
Ileum, % | |||
 G0/G1 phase cells | 73.57 ± 2.04 | 68.74 ± 1.98 | 0.128 |
 S phase cells | 17.78 ± 0.90 | 21.64 ± 1.43 | 0.052 |
 G2 + M phase cells | 8.10 ± 1.05 | 9.13 ± 1.11 | 0.521 |
 Proliferating index | 26.04 ± 1.90 | 30.89 ± 2.27 | 0.140 |